The American Australian Association (AAA) is proud to announce that Professor Ian Frazer, named Australian of the Year 2006 for his pivotal work on the human papilloma virus, will be the keynote speaker at Boston Biorelationships on Friday May 4, 2007.
Professor Frazer laid the groundwork for the development of vaccines to prevent infections caused by the papilloma virus.
After the keynote address, a panel of senior pharmaceutical and life sciences representatives will discuss how world-class Australian research is being commercialized and marketed through global partnerships.
The panel includes:
— Barbara Yanni, Vice President and Chief Licensing Officer, Merck & Co., Inc.
— William R. Griffith, Practice Group Leader, Life Sciences Transaction Group, Reed Smith LLP.
Biorelationships is the AAA’s annual biotech conference held in Boston since 2000.
Biorelationships features:
— Pre-BIO spotlight event for Australian biotech companies
— High profile Australian presenting companies
— Opportunities for pharmaceutical companies to meet premier Australian biotech innovators
Australian biotech is a commercial success story or, rather, a series of them.
Hear how international companies recognize the strength of Australia’s maturing biotech products and leverage opportunities for profitability.
Boston Biorelationships has the strong support of Australian Government representatives, Invest Australia, Victorian State Government, Austrade and the City of Melbourne and the highest profile portfolio of presenting companies. Presenting companies include Merck, CSIRO, the Australian Stem Cell Centre, Wyeth, Genzyme and Bristol-Myers Squibb.